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Background:  Five decades after its introduction, the Glenn shunt remains an integral step for patients undergoing single ventricle 
palliation. Mid-term outcomes of the original experience were previously reported. The aim of this study was to perform a longitudinal follow 
up of the original cohort of patients who underwent the Glenn shunt.
methods:  We preformed a retrospective study of the original cohort of patients who underwent Glenn shunt at Yale between 1958-1988. 
Electronic medical records and chart review up to current era were used to collect comprehensive data. Kaplan-Meier survival curves and 
statistical analysis were performed.
results:  91 patients underwent a Glenn shunt at an average age of 6.6 ± 2.5 years, of which 89 were a classic Glenn shunt. Median 
overall survival was 43 years (95% CI 39.5-46.5) while median survival from the Glenn shunt was 31.4 years (95% CI 23.9-38.9). 46 
patients died, 7 in the early post-operative period and 39 late deaths. 26 were lost to follow up. 19 patients remain alive with active clinical 
follow up, 6 of whom still live with their classic Glenn shunt without conversion to bidirectional Glenn. Following original Glenn, the most 
common subsequent operative procedures were Fontan (n=35), BT shunt (n=14), biventricular repair (n=8), axillary arteriovenous fistula 
(n=8), central shunt (n=3), tricuspid valve repair (n=2), and cardiac transplantation (n=2). Overall, 26 patients (31%) developed pulmonary 
arteriovenous (AV) fistula with 11 patients (42%) requiring coil embolization. There were a total of 28 patients who developed arrhythmias, 
mostly in the tricuspid atresia group (n=16), with the majority being atrial tachyarrhythmias (48%). 16 patients required permanent 
pacemaker placement for sinus node dysfunction.
Conclusion:  The Glenn shunt continues to provide an excellent staged palliation in single-ventricle patients and a bridge to two-ventricle 
repair half a century from its inception. Most patients required subsequent surgical interventions. Arrhythmias and pulmonary AV fistulas 
were common among single ventricle cohort. Quality of life evaluation of the surviving patients would be an important outcome measure for 
future investigation.
